AbbVie Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
161.63
|
|
Average Rating
|
3.77
|
|
# Strong Buys
|
8
|
|
# Buys
|
6
|
|
# Holds
|
10
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
3.57
|
3.66
|
0.09
|
2.52%
|
|
2022-06-30
|
3.31
|
3.37
|
0.06
|
1.81%
|
|
2022-03-31
|
3.14
|
3.16
|
0.02
|
0.64%
|
|
2021-12-31
|
3.29
|
3.31
|
0.02
|
0.61%
|
|
2021-09-30
|
3.22
|
3.33
|
0.11
|
3.42%
|
|
2021-06-30
|
3.09
|
3.11
|
0.02
|
0.65%
|
|
2021-03-31
|
2.83
|
2.95
|
0.12
|
4.24%
|
|
2020-12-31
|
2.85
|
2.92
|
0.07
|
2.46%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
10.19
|
|
2021-12-31
|
12.70
|
|
2020-12-31
|
10.51
|
|
2019-12-31
|
8.94
|
|
2018-12-31
|
7.91
|
|
2017-12-31
|
5.59
|
|
2016-12-31
|
4.82
|
|
2015-12-31
|
4.28
|
|
2014-12-31
|
3.31
|
|
2013-12-31
|
3.14
|
|
2012-12-31
|
0.98
|